Apotheek nieuws
- Compensatievergoeding voor zorgmedewerkers met long-COVID
- US FDA launches pilot programme to help further accelerate development of rare disease therapies
- A novel label?free, pre?equilibrium assay to determine the association and dissociation rate constants of therapeutic antibodies on living cells
- Kura Oncology shares preclinical data for NSCLC treatment
- Everest Medicines' Xerava receives Taiwan FDA approval to treat complicated intra─abdominal infections in adult patients
- Evaluation of Midazolam-Ketamine-Allopregnanolone Combination Therapy against Cholinergic-Induced Status Epilepticus in Rats [Neuropharmacology]
- Biodistribution of Agmatine to Brain and Spinal Cord Following Systemic Delivery [Neuropharmacology]
- Sotatercept Gets Priority Review for Pulmonary Aterial Hypertension
- De ministeries van VWS en Buitenlandse Zaken ondertekenen samen met ruim 20 partijen Global Health Pact
- Impact of antibiotic pharmacokinetics in urine on recurrent bacteriuria following treatment of complicated urinary tract infections
- Rekening rijbewijskeuring duidelijker door aanpassing prestaties
- Lijkschouw in een instelling met langdurige zorg: beperkte zelfstandige inzet PA en VS mogelijk
- DADLE promotes motor function recovery by inhibiting cytosolic phospholipase A2 mediated lysosomal membrane permeabilization after spinal cord injury
- Nieuw pneumokokkenvaccin voor kinderen vanaf 2024
- US FDA grants Fast Track designation to Ideaya Biosciences' IDE161 to treat pretreated, advanced or metastatic HR+, Her2─, BRCA1/2 mutant breast cancer
03-10-2023
